Gary Goldstein, MD
Gastroenterology · Tucson, AZNPI 1952366791
Payments from drug & device makers
Across 487 payments — averaging $364.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$112K
- Takeda Pharmaceuticals U.S.A., Inc.$53K
- Braintree Laboratories, Inc.$7K
- Fujifilm Healthcare Americas Corporation$581
- Nestle Healthcare Nutrition Inc.$549
- Aimmune Therapeutics, Inc.$534
- plus $3K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 192 | $112,330 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $53,344 |
| Braintree Laboratories, Inc. | 31 | $7,074 |
| Fujifilm Healthcare Americas Corporation | 7 | $581 |
| Nestle Healthcare Nutrition Inc. | 40 | $549 |
| Aimmune Therapeutics, Inc. | 32 | $534 |
| Phathom Pharmaceuticals, Inc. | 30 | $530 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $402 |
| Johnson & Johnson | 23 | $327 |
| E.r. Squibb & Sons, L.L.C. | 2 | $250 |
| Sanofi | 9 | $206 |
| Medtronic | 2 | $190 |
| Gilead | 17 | $179 |
| Pfizer | 9 | $176 |
| Bristol Myers Squibb | 7 | $119 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Madrigal Pharmaceuticals | 3 | $72 |
| Lilly USA, LLC | 3 | $61 |
| Intercept Pharmaceuticals, Inc. | 3 | $53 |
| Enterra Medical, Inc. | 1 | $52 |
| Ardelyx, Inc. | 2 | $49 |
| Idorsia Pharmaceuticals US Inc | 3 | $49 |
| Novo Nordisk | 1 | $25 |
| Alfasigma USA, Inc. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Lucid Diagnostics Inc. | 1 | $18 |
| Evoke Pharma, Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
How this compares
$177,332 in reported general payments places this provider in the 85th percentile of 355 gastroenterology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Tucson
- Sam MoussaTucson$3.9M
- Bassel KissoTucson$2.3M
- Fadi DeebTucson$1.5M
- Sasha TalebanTucson$744K
- Rehan IftikharTucson$479K
- Craig GrossTucson$256K
- Rizwan SafdarTucson$98K
- Gary GottliebTucson$91K
- Joseph DavisChandler$7.4M
- Manreet KaurScottsdale$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.